home > drugs a-z list > kadian (morphine sulfate extended-release) drug center > kadian (morphine sulfate extended-release) drug - medication guide and patient information

Recommended Topic Related To:

Kadian

Introduction to Chronic Pain

You know it at once. It may be the fiery sensation of a burn moments after your finger touches the stove. Or it's a dull ache above your brow after a day of stress and tension. Or you may recognize it as a sharp pierce in your back after you lift something heavy.

It is pain. In its most benign form, it warns us that something isn't quite right, that we should take medicine or see a doctor. At its worst, however, pain robs us of our productivity, our well-being, and, for many of us suffering from extended illness, our very lives. Pain is a complex perception that differs enormously among individual patients, even those who appear to have identical injuries or illnesses.

In 1931, the French medical missionary Dr. Albert Schweitzer wrote, "Pain is a more terrible lord of mankind than even death itself." Today, pain has become the universal disorder, a serious and costly public health issue, and a challenge for famil...

Kadian

font size

PATIENT INFORMATION

If clinically advisable, patients receiving KADIAN (morphine sulfate extended-release) ®, or their caregivers should be given the following information by the physician, nurse, or pharmacist:

  1. Patients should be advised that KADIAN (morphine sulfate extended-release) ® contains morphine and should be taken only as directed.
  2. Patients should be advised that KADIAN (morphine sulfate extended-release) ® capsules should be swallowed whole (not chewed, crushed, or dissolved). Alternately, KADIAN (morphine sulfate extended-release) ® capsules may be opened and the entire contents sprinkled on a small amount of apple sauce immediately prior to ingestion. KADIAN (morphine sulfate extended-release) ® capsules or the contents of the capsules must not be chewed or crushed due to a risk of fatal overdose.
  3. Patients should be advised that KADIAN (morphine sulfate extended-release) ® 100 mg and 200 mg Capsules are for use only in opioid-tolerant patients. Special care must be taken to avoid accidental ingestion or use by individuals (including children) other than the patient for whom it was originally prescribed, as such unsupervised use may have severe, even fatal, consequences.
  4. Patients should be advised that the dose of KADIAN (morphine sulfate extended-release) ® should not be adjusted without consulting the prescribing health care provider.
  5. Patients should be advised to report episodes of breakthrough pain and adverse experiences occurring during therapy. Individualization of dosage is essential to make optimal use of this medication.
  6. Patients should be advised that KADIAN (morphine sulfate extended-release) ® may impair mental and/or physical ability required for the performance of potentially hazardous tasks (e.g., driving, operating machinery). Patients started on KADIAN (morphine sulfate extended-release) ® or whose dose has been changed should refrain from dangerous activity until it is established that they are not adversely affected.
  7. Patients should be advised that KADIAN (morphine sulfate extended-release) ® should not be taken with alcohol or other CNS depressants (sleeping medication, tranquilizers) except by the orders of the prescribing healthcare provider because dangerous additive effects may occur resulting in serious injury or death.
  8. Women of childbearing potential who become or are planning to become pregnant, should consult their prescribing healthcare provider prior to initiating or continuing therapy with KADIAN (morphine sulfate extended-release) ®.
  9. Patients should be advised that if they have been receiving treatment with KADIAN (morphine sulfate extended-release) ® for more than a few weeks and cessation of therapy is indicated, it may be appropriate to taper the KADIAN (morphine sulfate extended-release) ® dose, rather than abruptly discontinue it, due to the risk of precipitating withdrawal symptoms. Their prescribing healthcare provider should provide a dose schedule to accomplish a gradual discontinuation of the medication.
  10. Patients should be advised that KADIAN (morphine sulfate extended-release) ® is a potential drug of abuse. They should protect it from theft, and it should never be given to anyone other than the individual for whom it was prescribed.
  11. Patients should be advised that severe constipation could occur as a result of taking KADIAN (morphine sulfate extended-release) ® and appropriate laxatives, stool softeners and other appropriate treatments should be initiated from the beginning of opioid therapy.
  12. Patients should be instructed to keep KADIAN (morphine sulfate extended-release) ® in a secure place out of the reach of children. When KADIAN (morphine sulfate extended-release) ® is no longer needed, the unused capsules should be destroyed by flushing down the toilet.

Last reviewed on RxList: 1/11/2008
This monograph has been modified to include the generic and brand name in many instances.

Kadian - User Reviews

Kadian User Reviews

Now you can gain knowledge and insight about a drug treatment with Patient Discussions.

Here is a collection of user reviews for the medication Kadian sorted by most helpful. Patient Discussions FAQs

Report Problems to the Food and Drug Administration

 

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.


Chronic Pain/Back Pain

Find tips and advances in treatment.